Monthly Archives: June 2020

COVID 19 Impact Analysis: Medical Devices Market 2020, Emerging Technology Trends, Industry Size, Analysis, Statistics, CAGR Status, Top Companies

Global Medical Devices Market Research Report: By Product Type (Cardiac Monitoring, Diagnostic and Drug Delivery), Therapeutic Application (Gastrointestinal Surgery, General Surgery and Diagnostic Imaging), End User (Hospitals & Clinics, Diagnostic Centers and Research Laboratory) – Forecast till 2025

Pune, India – June 22, 2020 /MarketersMedia/

Medical Devices Market Overview

Medical devices are the primary equipment used for testing, diagnosing, and treating specific medical conditions. The world is facing a massive surge in medical conditions from various sources like chronic diseases, road accidents, and other conditions. On observing the global market trends, the global medical devices market is projected to grow over 20 % annual growth rate during the survey period. The chronic conditions are spreading at lightning speeds, and increasing old aged populations are the major factors driving this market. As the economies are growing, the healthcare facilities are also trying to improve their structures, which is directly beneficial for the global medical devices market.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/2869

With the increasing demands for better medical devices, the companies are investing in research & development programs for searching for new technologies and developing older techniques for expanding the market’s structure and accelerating the market. Economies are releasing hefty amounts for developing their medical structures, which are boosting the market’s growth during this period.

Apart from the extensive usage of medical devices, the global medical devices market is still struggling against the high overall device costs and data security issues in the connected devices. Data security is the primary factor responsible here because hackers or data thieves are always active to breach into data centers.

Global Medical Devices Market segments

The global medical devices market is segmented into three parts, which are:

Product types: Surgical devices, diagnostic devices, monitoring devices, and other devices fall in this segment.

Therapeutic applications: Medical devices are used in ear nose throat (ENT), surgeries, orthopedics, respiratory and other operations.

End-Users: Hospitals, clinics, research institutes, and other industries are using these devices.

Medical Devices Market Regional Summary

America, Europe, Asia Pacific, and The Middle East & African regions are the major regions observed for the global medical devices market.

The American region is the current market leader, with North America as the major shareholder. Well established healthcare facilities demand efficient devices, increasing severe medical patients, and other factors are responsible for the growth in this region.

The European region is the second-largest medical device market due to increasing awareness, investments in research & development programs, and other elements.

The Asia Pacific region it the next biggest market in this tally. This region will show the highest growth rates during the survey period due to rapidly developing economies, emphasis on improving the medical facilities, rise in chronic health conditions, and other critical factors.

The rest of the regions are also showing impressive results because of improving healthcare structures and demands for the latest technically evolved devices.

Medical Devices Industry News

The global medical devices market is growing with seamless future opportunities. Still, the factors like high device costs and dangers from the data breach are the factors limiting the market’s growth meter. The companies are readily acting against these factors to make it suitable for all sections. The North American region is the current market leader, and the Asia Pacific region will emerge as the fastest-growing market during the survey period.

Table Of Contents

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope Of The Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

…TOC Continued…

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/medical-devices-market-2869

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact Info:
Name: Akash Anand
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers, Pune – 411028, Maharashtra, India
Phone: 09607196888
Website: https://www.marketresearchfuture.com

Source URL: https://marketersmedia.com/covid-19-impact-analysis-medical-devices-market-2020-emerging-technology-trends-industry-size-analysis-statistics-cagr-status-top-companies/88964900

Source: MarketersMedia

Release ID: 88964900

Makara Commences Field Work at Rude Creek Gold Project, Yukon

VANCOUVER, BC / ACCESSWIRE / June 22, 2020 / Makara Mining Corp. (CSE:MAKA)(FSE:MKO)(OTC PINK:MAKAF) ("Makara" or the "Company") is pleased to announce that it has begun mobilizing crews to begin field work on the Rude Creek Gold Project ("Rude Creek" or the "Project") in the White Gold region of the Yukon, Canada. Field work in 2020 will consist of soil sampling and ground geophysics followed by reverse-circulation (RC) drilling.

Highlights

Rude Creek consists of two key prospects – Trombley and Northeast anomalies
Field work this summer will focus on the Northeast anomaly
Follow-up work in 2020 will consist of a detailed soil sampling and ground geophysical survey centred over last year's successful drilling
Reverse-circulation drilling is expected to be conducted later this year, based on the results of the above detailed soil and geophysical work

Details on the Rude Creek Exploration Program

The Rude Creek Property totals 4,157 hectares in area and is located in west-central Yukon, approximately 160 km south of Dawson City and 135 km northwest of Carmacks. Makara holds an option to earn a 70% interest in the Project (see news release dated May 12, 2020).

Summer and fall are generally the most attractive seasons of the year to conduct field work in the Yukon. Field crews were mobilized to the Rude Creek project area late last week. Work will include the collection of approximately 150 soil samples (in the C-horizon) over a close-spaced grid measuring 750 metres by 250 meters.

Concurrently with soil sampling, a ground geophysical survey consisting of induced polarization and resistivity ("IP/resistivity") will be conducted over the same grid. IP/resistivity is a tool commonly used in mineral exploration to detect electrical chargeability and conductivity in the sub-surface. At the Northeast anomaly, it is hoped that anomalous levels of gold in the soil will be detected and those anomalies will coincide with areas of conductivity or resistivity, suggesting the presence of gold-related faults.

A drone-based lidar (a laser-based tool used for generating very detailed topographic maps) survey may also be conducted later this summer. This tool could also greatly aid in the detection of potentially gold-bearing fault structures.

For reference, the entire Northeast soil anomaly (defined as greater than or equal to 10 ppb gold in soil) currently measures 1,600 metres east-west by 1,000 metres north-south. Therefore, the detailed grid in 2020 will represent approximately 10% of the entire Northeast soil anomaly. Sample spacing, however, will be tight (25-metre centres along lines 50 metres apart; versus 50-metre centres, 200 meters apart), enhancing the Company's ability to position drill holes in the most prospective locations.

The Northeast anomaly contains gold-in-soil as high as 366 ppb, 356 ppb and 319 ppb and remains open in all directions. Work in future years will focus on expanding the soil anomaly beyond its currently defined boundaries.

GroundTruth Exploration

Soil sampling and ground geophysics described above will be conducted by GroundTruth Exploration Inc. ("GroundTruth"), under the direction of 0890763 B.C. Ltd., the operator and vendor of the Rude Creek Project.

For background, GroundTruth (and its predecessor) was one of the key pioneers of the concept that soil samples should be collected from the C-horizon (as opposed to the shallower B-horizon) in order to most effectively explore for gold in the unglaciated terranes of the Yukon. Sampling of the C-horizon was pivotal in the success of gold exploration in the Yukon since the late 1990s, especially at the Coffee Creek and White Gold (Golden Saddle) discoveries where the GroundTruth team used C-horizon soils as a prime targeting tool.

To be effective, every element of the sampling operation must be meticulously planned, executed and monitored. Through years of experience, GroundTruth has mastered this process and has successfully scaled out to some of the largest soil sampling programs in the world. GroundTruth has standardized every element of the sampling program, from barcode scanned sample identification tags, to geo-referenced photos of every sample and sample site.

"We are very excited to begin the exploration program on this new acquisition over this coming summer and we are diligently working towards exploring and developing our portfolio of properties in the coming year," stated Grant Hendrickson, President and Chief Executive Officer. "The White Gold region is a very active gold exploration area of the Yukon, hosting Western Copper's Casino project, Newmont's Coffee Creek project and White Gold's Golden Saddle and Vertigo discoveries. Rude Creek is approximately 20 kilometres on-trend from Coffee Creek and hosts Coffee Creek style gold mineralization."

Qualified Person

Technical information in this news release has been approved by Grant Hendrickson, P.Geo. and ‘Qualified Person' as defined under Canadian National Instrument 43-101 Standards of Disclosure for Mineral Projects.

About the Company

Makara Mining Corp. (CSE:MAKA)(FSE:MKO)(OTC PINK:MAKAF) is a mineral exploration company focused on the acquisition, exploration and development of gold properties. The Company is based in Vancouver, B.C and holds an option over the Rude Creek Property located in the Yukon and the Kenora Gold Property located in Northwestern Ontario. Additional information about the Company is available at www.makaramining.com.

ON BEHALF OF THE BOARD OF DIRECTORS

Grant Hendrickson
Director and Chief Executive Officer
Telephone: 604-372-3707
Email: grant@makaramining.com

Forward-Looking Statements

This news release contains certain forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, and statements respecting the Company's anticipated exploration program at Rude Creek are "forward-looking statements." Forward-looking statements are subject to a number of risks and uncertainties, including those detailed from time to time in filings made by the Company with securities regulatory authorities, which may cause actual outcomes to differ materially from those discussed in the forward-looking statements. These factors should be considered carefully and readers are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements and information contained in this news release are made as of the date hereof and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.

SOURCE: Makara Mining Corp.

ReleaseID: 594486

Assessing the Coronavirus Impact: Swab and Viral Transport Medium Market to Witness High Demand Growth with Rising Patient Numbers and Faster Product Approval Processes

The COVID-19 pandemic is expected to see an increase in swab and viral transport product manufacturing capabilities to meet the unprecedented requirements of healthcare organizations, on a global scale.

DUBAI, UAE / ACCESSWIRE / June 22, 2020 / The staggering rise in the number of global COVID-19 cases and the inadequacy of laboratory-based testing infrastructure are key factors that are encouraging the use of new swab and viral transport mediums. In addition, government bodies are pushing for faster approval of products in the market to enable faster access into open markets. These trends will support the swab and viral transport medium market until the end of the pandemic.

The swab and viral transport medium market is projected to rise at a sluggish 1.2% CAGR during the forecast period between 2020 and 2030. Rising incidences of infectious diseases and massive growth of cities with high population densities, bolsters the demand for swab and viral transport mediums. Innovations in terms of accuracy, faster results, and ease of use will support the industry even after the outbreak comes to an end.

"In early 2020, the United States FDA approved the application of synthetic swabs for coronavirus testing. This enables potential patients to self-administer the tests, minimizing exposure of the virus to medical professionals. In addition, manufacturers are pushing for the development of polyester swabs in large numbers to meet the rising need for COVID-19 diagnostics," states the FMI analyst.

For more insights into the Market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-11195

Swab and Viral Transport Medium Market- Critical Takeaways

Viral swabs will lead in terms of market revenue, particularly driven by the integration of PCR tech in new products.
Viral transport medium is gaining substantial revenue share, supported by protocol recommendations by regulatory bodies such as the CDC and WHO.
Apart from COVID-19, hantavirus, and influenza testing and transport applications will remain key contributors to market development.
Hospitals and clinics will account for major market share owing to rising healthcare investments and the threat of infectious disease.
North America will remain a dominant force in the swab and viral transport medium market owing to the presence of major market players, and growing emphasis on COVID-19 testing.

Swab and Viral Transport Medium Market- Drivers

The expansion of the diagnostics industry supports the demand for swab and viral transport medium.
An exponential rise in infectious diseases including COVID-19 and influenza encourage the production of swabs and viral transport mediums.
Faster regulatory approval of new product offerings aids market revenue growth.
Investments in associated tech research by government bodies is set to drive product development in the industry.

Swab and Viral Transport Medium Market- Restraints

High cost of development for viral swabs for varied pathogens hinders market growth.
Lack of accuracy through false positives and negatives hinder adoption in the swab and viral transport medium market.

Coronavirus Impact on Swab and Viral Transport Medium Market

Major swab and viral transport medium manufacturers are struggling to keep up with the massive global demand. Despite government funding and fiscal aid, shortages are likely to impact the market, even as producers push to ramp up production. In addition, swabs for COVID-19 tests need unique designs and materials, which impacts prospects in the market.

Disruptions to raw material supply chains such as plastics and reagents, are impacting hospital and clinic access to swabs and viral transport mediums. Governments are consequently directing manufacturing resources to keep up with the rising demand for testing. On the other hand, the high demand for COVID-19 related products is impacting swabs and viral transport mediums for other diseases which is impacting market growth. Bringing the pandemic under control is essential to maintain pre-coronavirus levels of demand.

For information on the research approach used in the report, request methodology@ https://www.futuremarketinsights.com/askus/rep-gb-11195

Competitive Landscape

The top manufacturers in the fragmented swab and viral transport medium market are pushing for new product launches and are also investing in ramping up production capacities, to generate new revenue streams. Also, product approvals will remain essential in market strategies.

For instance, Thermo Fisher Scientific has announced a FDA- breakthrough device designation for its new assay for oncomine precision. Also, ChromaCode has received and emergency use authorization by the FDA for its SARS-CoV-2-PCR test.

Key players in the swab and viral transport medium market include but are not limited to MWE, Becton, Titan Biotech Ltd., Dickinson & Company, Deltalab, Cardinal Health Inc., VIRCELL S.L., McKesson Corporation, COPAN Diagnostics Inc., and Thermo Fisher Scientific Inc.

About the Study

The study offers an in-depth projection of the swab and viral transport medium market. Global, regional and national-level analysis of the latest trends influencing the swab and viral transport medium market is covered in this FMI report. The study provides insights according to product type (viral transport medium and virus swabs), indication (influenza, respiratory syncytial virus, mumps virus, adenovirus, rhinovirus, herpes simplex virus, varicella zoster virus, and others), end user (diagnostic laboratories, hospitals & ASCs, specialty clinics, and others), in seven regions (North America, Latin America, Europe, South Asia, East Asia, Oceania, and MEA).

Explore FMI's Coverage of the Healthcare, Pharmaceuticals, and Medical Devices Industry

Positron Emission Tomography (PET) Scanners Market– Insights on the global positron emission tomography (PET) scanners market through FMI's report covering detailed analysis for projection period 2016-2026.

Vagus Nerve Stimulator Market– FMI's study on the global vagus nerve stimulator market covers the latest trends, innovations, key players, and popular strategies for the period 2018-2028.

Healthcare Regulatory Affairs Outsourcing Market– Obtain analysis on the healthcare regulatory affairs outsourcing market through FMI's report covering competitive analysis, key regions, and segmental analysis for 2017-2025.

About Future Market Insights

Expert analysis, actionable insights, and strategic recommendations of the veteran research team at FMI helps clients from across the globe with their unique business intelligence requirements. With a repository of over a thousand reports and 1 million+ data points, the team has scrutinized the healthcare, pharmaceuticals, and medical devices sector across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services. Reach out to explore how we can help.

Contact:

Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Market Report: https://www.futuremarketinsights.com/reports/swab-and-viral-transport-medium-market
Press Release Source: https://www.futuremarketinsights.com/press-release/swab-and-viral-transport-medium-market

SOURCE: Future Market Insights

ReleaseID: 594715

Scrutinizing the Coronavirus Impact: Unsaturated Polyester Resin Production Impacted by Supply Chain Disruptions in Manufacturing Sector

Major producers of unsaturated polyester resin are expected to push for greater market presence in new markets through investments in R&D for novel product applications through and after the pandemic

ROCKVILLE, MD / ACCESSWIRE / June 22, 2020 / The global unsaturated polyester resin market is projected to expand 1.5x and rise at a healthy 5.3% CAGR, for the projection period 2020 – 2030. Following the coronavirus outbreak in 2019, the applications of unsaturated polyester resins has dropped in the manufacturing sector, owing to major supply chain disruptions. In addition, the sudden slump in new manufacturing orders, and the growing threat of recession are also impacting the market.

As per the study published by Fact.MR, end user verticals such as construction, electrical, marine, and transport will face substantial obstacles throughout the duration of the pandemic. Issues of raw materials and supplies will hurt short term prospects. On the other hand, unsaturated polyester resin applications for marine applications will partially mitigate losses during this period.

"The global manufacturing sector has been taking measures to minimize the impact of the COVID-19 pandemic on regular operations. Declining oil prices, hesitant investors and capital availability issues will remain. The drop in the global economy and the rising production of unsaturated polyester resins by end users on-site will affect demand through 2020," says the FACT.MR study.

Request report sample of 250+ pages to gain detailed market insights at-

https://www.factmr.com/connectus/sample?flag=S&rep_id=4731

Unsaturated Polyester Resin Market- Critical Takeaways

Orthopthalic unsaturated polyester resin will remain highly sought after owing to low cost, thermal stability, corrosion resistance, and mechanical characteristics
PDCPD is gaining traction owing to applications in manufacture of tractors, trucks, buses, and construction equipment
Building and construction applications will contribute substantially to market revenue owing to wide ranging uses in the sector
Offshore oil and gas exploration and drilling activities provide remunerative opportunities in the market, with demand for fiber reinforced plastics in the sector
Asia Pacific followed by North America are the dominant markets for unsaturated polyester resins, driven by growth in construction, marine, transport and electronic industry

Unsaturated Polyester Resin Market- Drivers

Developments in construction materials and applications in pipe and tank products will drive market growth
Investments in energy saving, environment friendly products will expand profit pools
Research on lower thickness, recyclability, corrosion resistance, and physical strength for bio-based resins generate lucrative growth opportunities
Extensive applications of plastic composites in myriad end use verticals are set to support market developments

Unsaturated Polyester Resin Market- Restraints

Environmental concerns associated with the production and use of unsaturated polyester resin hinders market growth
Availability of alternatives such as nylon and epoxy resins limit demand for unsaturated polyester resin

COVID-19 Impact on Unsaturated Polyester Resin Market

The coronavirus outbreak has resulted in major disruptions in the unsaturated polyester resin supply chain, with large scale production cuts, increased costs, and shortages of raw materials. The high reliance of the global industry on Chinese producers has exposed cracks in the industry. In addition, restrictions on imports and exports also hurts market prospects.

Consequently, end users are seeking alternative supply sources within the destination countries to maintain supply chains. Also cost volatility of petroleum products is impacting the market. Recovery is likely to be strong after the outbreak is brought under control, owing to the wide scope of applications for unsaturated polyester resins.

The global unsaturated polyester resin market report includes 193 figures, 74 data tables and a table of contents. You can also find a detailed market segmentation on

https://www.factmr.com/report/4731/unsaturated-polyester-resin-market

Competitive Landscape

Major unsaturated polyester resin manufacturers are pushing for strategic mergers and acquisitions. Also, major brands are integrating distribution and production processes. For instance, BASF SE has provided Red Avenue Co. a license for the production of unsaturated polyester resin products.

LERG SA, INEOS, Tianhe Resin Co. Ltd., BASF SE, Scott Bader Co. Ltd., Polynt, UPC Group, Koninklijke DSM N.V., U-PICA Co. Ltd., Dow, Eternal Materials Co. Ltd., and Satyen Polymers Pvt. Ltd., are some of the key unsaturated polyester resin producers.

About the Study

The study offers readers an exhaustive market forecast of the unsaturated polyester resin market. Global, regional and national-level analysis of the latest industry trends influencing the unsaturated polyester resin market is covered in this FACT.MR report. The study provides actionable insights on unsaturated polyester resin market according to product (DCPD, Orthopthalic, Isophtalic, and others), and end use (building & construction, tanks & pipes, electrical, marine, transport, artificial stones, and others) across six regions (North America, Latin America, Europe, South Asia & Oceania, East Asia, and MEA).

Explore Fact.MR's Coverage of the Global Chemical & Materials Industry

Colloidal Silica Market– Get insights on the global colloidal silica market through FACT.MR's report covering detailed quantitative and qualitative analysis for projection period (2019-2029).

Alpha Olefin Sulfonates Market– FACT.MR's study on the global alpha olefin sulfonates market covers new trends, tech advancements, key players, and prominent strategies for the course of the period 2019-2029.

Nanoporous Materials Market– Obtain analysis on the global nanoporous materials market through FACT.MR's report covering competitive analysis, key regions, and segmental analysis for 2018-2028.

About Fact.MR

Expert analysis, actionable insights, and strategic recommendations of the veteran research team at FACT.MR helps clients from across the globe with their unique business intelligence requirements. With a repository of over a thousand reports and 1 million+ data points, the team has scrutinized the chemical & materials sector across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services. Fact.MR's latest market reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition.

Contact:

Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
PR- https://www.factmr.com/media-release/1483/global-unsaturated-polyester-resin-market

SOURCE: FactMR

ReleaseID: 594716

Greenpro Approves $2 million Common Stock Buy Back

HONG KONG / ACCESSWIRE / June 22, 2020 / Greenpro Capital Corp. (NASDAQ:GRNQ) (the "Company") announced that the Company's board of directors has approved a common stock buyback program which the Company can repurchase up to $2 million of the currently outstanding shares of the Company's common stock, over a period of 3 months through open market purchases, privately-negotiated transactions, or otherwise in compliance with Rule 10b-18 under the Securities Exchange Act of 1934. Periodic buybacks are expected throughout the third quarter of 2020.

CK Lee, CEO of GRNQ said: "Our Company is committed to maximizing shareholder value through various options, including through the payment of dividends and buyback programs. It is our assessment that an immediate buyback program provides a meaningful way to deliver maximum shareholder value."

About Greenpro Capital Corp.

Headquartered in Hong Kong with strategic offices across Asia, Greenpro Capital Corp. (Nasdaq:GRNQ) is a business incubator and multinational conglomerate with a diversified business portfolio comprising finance, technology, banking, CryptoSx for STOs, health and wellness and fine art. With 30 years of experience in various industries, Greenpro has been assisting and supporting businesses and High-Net-Worth-Individuals to capitalize and securitize their value on a global scale through the provision of cross-border business solutions, spinoffs on major stock exchanges and accounting outsourcing services to small and medium-size businesses located in Asia. The comprehensive range of cross-border business services include, but are not limited to, trust and wealth management, listing advisory services, transaction services, cross-border business solutions, record management services, accounting outsourcing services and tax advisory services. We also operate venture capital businesses, including business development for start-ups and high growth companies, covering finance, technology, FinTech, and health and wellness. For further information regarding the Company, please visit http://www.greenprocapital.com.

About the Millennium Fine Art business

GRNQ is spinning off one (1) million shares of Millennium Fine Art, Inc. ("MFAI"), as a dividend to its shareholders of record on July 1, 2020. GRNQ's wholly owned subsidiary MFAI, is incorporated in Wyoming, and intends to conduct an IPO and list on either the Nasdaq or NYSE. MFAI intends to take the Millennium Sapphire and other art masterpieces on a world tour of museums once they are open to the public, as well as to develop a virtual reality platform including sales and live art auctions.

Forward-Looking Statements
This press release contains forward-looking statements, particularly as related to, among other things, the business plans of the Company, statements relating to goals, plans and projections regarding the Company's financial position and business strategy. The words or phrases "plans," "would be," "will allow," "intends to," "may result," "are expected to," "will continue," "anticipates," "expects," "estimate," "project," "indicate," "could," "potentially," "should," "believe," "think," "considers" or similar expressions are intended to identify "forward-looking statements." These forward-looking statements fall within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934 and are subject to the safe harbor created by these sections. Actual results could differ materially from those projected in the forward-looking statements as a result of a number of risks and uncertainties. Such forward-looking statements are based on current expectations, involve known and unknown risks, a reliance on third parties for information, transactions or orders that may be cancelled, and other factors that may cause our actual results, performance or achievements, or developments in our industry, to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from anticipated results include risks and uncertainties related to the fluctuation of local, regional, and global economic conditions, the performance of management and our employees, our ability to obtain financing, competition, general economic conditions and other factors that are detailed in our periodic reports and on documents we file from time to time with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date, and the Company specifically disclaims any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.

GRNQ has 59.16 million shares outstanding and 4.88 million shares in the float.

Gilbert Loke, CFO, Director
Greenpro Capital Corp.
Email: ir.hk@greenprocapital.com
Phone: +852-3111 7718

Contact Dennis Burns, Investor Relations.
Tel (567) 237-4132
dburns@nvestrain.com

For more information on the Millennium Sapphire please visit:
www.millenniumsapphire.com
Facebook: millennium sapphire

SOURCE: Greenpro Capital Corp

ReleaseID: 594714

Former NSA and Western Union Executives Join Cred Leadership Team

Former NSA and Western Union Executives Join Cred Leadership Team

Security and financial technology veterans join Cred to democratize financial services

SAN FRANCISCO, CA / ACCESSWIRE / June 22, 2020 / Cred, the leading global blockchain-based financial services platform serving customers in 190 countries, announced today that it has added new executives to the already powerful roster. Daniel Goldstein joins Cred as Chief Technology Officer and Bethany De Lude will take over all security operations as Chief Information Security Officer. Each executive brings a 25+ year proven track record of security and financial innovation, spanning blockchain technology, payments, risk engineering, and compliance.

Bethany De Lude, a former NSA employee, served as the first CISO for the Federal Judiciary and has held security leadership positions at PricewaterhouseCoopers, Riggs Bank, and the Corporate Executive Board. Prior to joining Cred, Bethany was the first CISO for the Federal Judiciary and held a security leadership position at the US National Security Agency.

"I look forward to joining a team of true professionals and innovators whose mission is to offer equitable, inclusive financial services using blockchain technology," said Bethany De Lude. "I am eager to bring my knowledge of information security and help Cred build a world-class security organization as it continues its growth trajectory."

Daniel Goldstein served as an executive at Western Union, Symantec, and Emergent Technology. His teams have built next-generation digital fraud detection, Big Data systems, global payments, and he led the development of Emergent Technology's Responsible Gold supply chain solution and G-Coin digital token.

"I'm thrilled to support Cred's mission of providing more equitable and inclusive financial and services utilizing the best of blockchain and traditional fintech," said Danny Goldstein, Chief Technology Officer at Cred. "This team has a strong track record of innovation and understands how to apply new technology to solve current industry problems and create significant value."

"Cred is fortunate to attract some of the best talent in the world and Bethany and Daniel are no exception," said Dan Schatt CEO and Co-Founder of Cred. "Daniel's deep technical expertise and Bethany's exceptional information security leadership will prepare Cred to scale its business to support lending and blockchain transactions that will grow into the billions of dollars."

Bethany De Lude and Danny Goldstein's appointment follows the significant growth and profitability Cred has experienced. Cred is a licensed lender headquartered in the San Francisco Bay Area, supporting over a dozen partners with its industry-leading crypto-backed lending and borrowing platform. Founded by PayPal veterans, Cred powers the financial services offerings for some of the most well-known blockchain organizations in the world including the Litecoin Foundation, Bitcoin.com, and Uphold. Cred offers crypto-based interest accounts providing highly competitive interest rates on Bitcoin, Ether, and stablecoins and crypto-backed loans allowing clients to access liquidity in USD.

Contact Information:

Contact Name: Meghan Gardler, Senior Director of Marketing
Website: https://mycred.io/
Email: Meghan@mycred.io

SOURCE: Cred

ReleaseID: 594646

Group Ten Announces Completion of Earn-In Agreement Resulting in 100% Ownership of the Stillwater West PGE-Ni-Cu-Co Project in Montana, USA

VANCOUVER, BC / ACCESSWIRE / June 22, 2020 / Group Ten Metals Inc. (TSX.V:PGE)(OTCQB:PGEZF)(FSE:5D32) (the "Company" or "Group Ten") announces that it has satisfied all earn-in requirements set out in the agreement announced June 27, 2017 (the "Stillwater Agreement") and now has 100% ownership of the Stillwater West property, subject to a 2% NSR royalty interest which includes a 1% buy-down provision. The Stillwater Agreement was amended prior to completion to include an updated area of interest clause to incorporate an expanded claim block, which has more than doubled since the acquisition date.

Group Ten President and CEO, Michael Rowley, stated, "We are very pleased to have completed the earn-in requirements at Stillwater West, securing an exceptional land package and strengthening our position beside Sibanye-Stillwater, the world's largest platinum producer, in the productive and metal-rich Stillwater Igneous Complex. Our systematic approach to consolidating the district and compiling all available data resulted in the confirmation of Platreef-style nickel-copper sulphide mineralization, enriched in palladium, platinum, rhodium, cobalt, and gold, in our 2019 drill campaign, which returned some of the best mineralized intervals to date in the district on a grade-thickness basis. We are now advancing drill-defined mineralization towards delineation of formal resources in four of the five most advanced target areas as we continue to demonstrate the potential for much larger mineralized systems than have been recognized previously in the district. We look forward to providing further updates on that work, in addition to announcing our 2020 exploration plans, in the near future."

With respect to Group Ten's other projects, the Company is currently soliciting and reviewing expressions of interest on its non-core assets (all of which are 100%-owned) as part of its focus on Stillwater West.

Summaries of all assets presently in Group Ten are provided below:

Stillwater West, Montana, USA
Applying Bushveld deposit models to North America's premier PGE district

100% owned, subject to a 2% NSR royalty interest, which includes a buy-down provision to 1%;
At 54 square kilometers, Stillwater West establishes Group Ten with the second largest land position in the western hemisphere's most valued and productive palladium and platinum district, sharing the Stillwater Igneous Complex with Sibanye-Stillwater's three producing mines, 60km from a world-class metallurgical complex;
The district is known for the size and grade of its palladium-platinum mines, which are the highest grade in the world and the largest outside of Africa and Russia, yet remains surprisingly underexplored overall;
Group Ten is the first to systematically explore for Platreef-style mineralization, targeting bulk tonnage PGE-Ni-Cu mineralization in the lower Stillwater complex based on known similarities with South Africa's Platreef district. The north limb of the Bushveld complex, or Platreef, is host to some of the largest, most profitable, and longest-lived nickel-copper sulphide hosted PGE mines in the world, including Anglo American's Mogalakwena mine, and Ivanhoe's Platreef mine;
The Company also has target areas focused on more conventional reef-type mineralization;
Group Ten's 2019 drill program returned some of the longest mineralized intercepts ever reported in the district, confirming the presence of "Platreef-style" mineralization in key target areas, and enabling 3D block modeling of drill-defined mineralization in four target areas which are now being advanced to maiden resources; and
In addition to the palladium, platinum, nickel, copper, and cobalt mineralization demonstrated to date, recent work has expanded the understanding and potential for high-grade gold and rhodium at Stillwater West.

Black Lake – Drayton Gold Project, Northwest Ontario, Canada
District-scale high-grade gold project adjoining Treasury Metals, Northwest Ontario

100% owned, subject to only standard royalties on certain claim blocks, all of which have buy-down provisions;
137 square kilometer land position adjoining Treasury Metals' recently consolidated high-grade gold Goliath-Goldlund project, in the Rainy River district of Northwest Ontario;
Substantial database with more than 20 historic mineral occurrences, multiple high-grade bulk samples, and over 127 drill holes, in addition to geological, geochemical and geophysical data;
43% of past drill holes intercepted gold or copper mineralization, however past work did not adequately test the mineralized zones which are now better understood in the area; and
Much of the project's more than 30 km of strike length remains untested, despite the success of neighboring deposits and the broader Abrams‐Minnitaki Lake archean greenstone belt, which now hosts more than 10 million ounces gold.

Kluane PGE-Ni-Cu Project, Southwest Yukon, Canada
District-scale asset adjoining one of largest undeveloped PGE-Ni-Cu deposits in the world

100% owned, subject to only standard royalties on certain claim blocks, all of which have buy-down provisions; and
At 255 square kilometers, Group Ten's Kluane PGE-Ni-Cu project is the largest land position in the Kluane Ultramafic Belt, a mafic-ultramafic system that extends from northern British Columbia through the Yukon to central Alaska and hosts multiple PGE-Ni-Cu deposits, including the Nickel Shäw project now being advanced by Nickel Creek Platinum Corp.

Yankee-Dundee Project, Southeast BC, Canada
Royalty payments plus back-in rights at a past-producing Au-Ag-Pb-Zn mine

Group Ten may receive up to $4 million or more by way of cash and royalty payments, depending on mine performance, commodity markets, and other factors, subject to specified production milestones as defined by a 2013 sale agreement on the past-producing Yankee-Dundee gold-silver-lead-zinc mine in Southeast British Columbia; and
The Company maintains a back-in right on the project in the event that certain milestones are not met.

Duke Island Ni-Cu-PGE Project, Southeast Alaska, USA
Multiple Ni-Cu-PGE targets in the Alexander platinum belt

100% owned, subject to a 1% royalty;
31 claims located in the Alexander Platinum Belt of SE Alaska, 50 kilometers south of Ketchikan and 94 kilometers northwest of Prince Rupert, with demonstrated nickel, copper and PGEs values in mafic/ultramafic host rocks.

Mines and Money EMEA Online Event

Group Ten Metals is pleased to announce that the Company will be participating in Mines and Money's online EMEA (Europe, the Middle East and Africa) event June 30th to July 2nd with some of the most prominent names in the mining industry. Details of the event are available here: https://minesandmoney.com/online/emea/

About Stillwater West

The Stillwater West PGE-Ni-Cu project positions Group Ten as the second largest landholder in the Stillwater Complex, adjoining and adjacent to Sibanye-Stillwater's Stillwater, East Boulder, and Blitz platinum group elements ("PGE") mines in south central Montana, USA1. The Stillwater Complex is recognized as one of the top regions in the world for PGE-Ni-Cu mineralization, alongside the Bushveld Complex and Great Dyke in southern Africa, which are similar layered intrusions. The J-M Reef, and other PGE-enriched sulphide horizons in the Stillwater Complex, share many similarities with the highly prolific Merensky and UG2 Reefs in the Bushveld Complex, while the lower part of the Stillwater Complex also shows the potential for much larger scale disseminated and high-sulphide PGE-Ni-Cu deposits, possibly similar to Platreef in the Bushveld Complex2. Group Ten's Stillwater West property covers the lower part of the Stillwater Complex along with the Picket Pin PGE Reef-type deposit in the upper portion, and includes extensive historic data, including soil and rock geochemistry, geophysical surveys, geologic mapping, and historic drilling.

About Group Ten Metals Inc.

Group Ten Metals Inc. is a TSX-V-listed Canadian mineral exploration company focused on the development of high-quality platinum, palladium, nickel, copper, cobalt and gold exploration assets in top North American mining jurisdictions. The Company's core asset is the Stillwater West PGE-Ni-Cu project adjacent to Sibanye-Stillwater's high-grade PGE mines in Montana, USA. Group Ten also holds the high-grade Black Lake-Drayton Gold project in the Rainy River district of northwest Ontario and the Kluane PGE-Ni-Cu project on trend with Nickel Creek Platinum‘s Wellgreen deposit in Canada‘s Yukon Territory.

About the Metallic Group of Companies

The Metallic Group is a collaboration of leading precious and base metals exploration companies, with a portfolio of large, brownfields assets in established mining districts adjacent to some of the industry's highest-grade producers of silver and gold, platinum and palladium, and copper. Member companies include Metallic Minerals in the Yukon's high-grade Keno Hill silver district and La Plata silver-gold-copper district of Colorado, Group Ten Metals in the Stillwater PGM-nickel-copper district of Montana, and Granite Creek Copper in the Yukon's Minto copper district. The founders and team members of the Metallic Group include highly successful explorationists formerly with some of the industry's leading explorer/developers and major producers. With this expertise, the companies are undertaking a systematic approach to exploration using new models and technologies to facilitate discoveries in these proven, but under-explored, mining districts. The Metallic Group is headquartered in Vancouver, BC, Canada and its member companies are listed on the Toronto Venture, US OTC, and Frankfurt stock exchanges.

Note 1: References to adjoining properties are for illustrative purposes only and are not necessarily indicative of the exploration potential, extent or nature of mineralization or potential future results of the Company's projects.

FOR FURTHER INFORMATION, PLEASE CONTACT:

Michael Rowley, President, CEO & Director
Email: info@grouptenmetals.com Phone: (604) 357 4790
Web: http://grouptenmetals.com Toll Free: (888) 432 0075

Forward-Looking Statements

Forward Looking Statements: This news release includes certain statements that may be deemed "forward-looking statements". All statements in this release, other than statements of historical facts including, without limitation, statements regarding potential mineralization, historic production, estimation of mineral resources, the realization of mineral resource estimates, interpretation of prior exploration and potential exploration results, the timing and success of exploration activities generally, the timing and results of future resource estimates, permitting time lines, metal prices and currency exchange rates, availability of capital, government regulation of exploration operations, environmental risks, reclamation, title, and future plans and objectives of the company are forward-looking statements that involve various risks and uncertainties. Although Group Ten believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the forward-looking statements. Forward-looking statements are based on a number of material factors and assumptions. Factors that could cause actual results to differ materially from those in forward-looking statements include failure to obtain necessary approvals, unsuccessful exploration results, changes in project parameters as plans continue to be refined, results of future resource estimates, future metal prices, availability of capital and financing on acceptable terms, general economic, market or business conditions, risks associated with regulatory changes, defects in title, availability of personnel, materials and equipment on a timely basis, accidents or equipment breakdowns, uninsured risks, delays in receiving government approvals, unanticipated environmental impacts on operations and costs to remedy same, and other exploration or other risks detailed herein and from time to time in the filings made by the companies with securities regulators. Readers are cautioned that mineral resources that are not mineral reserves do not have demonstrated economic viability. Mineral exploration and development of mines is an inherently risky business. Accordingly, the actual events may differ materially from those projected in the forward-looking statements. For more information on Group Ten and the risks and challenges of their businesses, investors should review their annual filings that are available at www.sedar.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Group Ten Metals Inc.

ReleaseID: 594700

Pacific Ventures Group Pays Off Variable Priced Convertible Note to Avoid Potential Equity Dilution, No Such Notes Remain on Balance Sheet

Cash Flow from Operations Contributes to Debt Pay Off

LOS ANGELES, CA / ACCESSWIRE / June 22, 2020 / Pacific Ventures Group, Inc. (OTC PINK:PACV) (the "Company"), a food and beverage holding company specializing in the distribution of consumer food, beverage and alcohol-related products, is pleased to announce that it has repaid and satisfied the convertible notes that were convertible into common stock at a discount to market. Currently, the Company has no variable priced convertible notes on its balance sheet.

Ms. Shannon Masjedi, Pacific Venture Group's Chief Executive Officer, commented, "As we have begun to generate cash flow from operations, we have repaid and satisfied the remaining outstanding convertible notes in order to avoid any further potential equity dilution. At this time, there are no variable priced convertible notes on our balance sheet. We look forward to keeping our shareholders and the Wall Street community updated as the company continues to meet its goals in becoming a major distributor of consumer food, beverage and alcohol-related products."

About Pacific Ventures Group, Inc.

Pacific Ventures Group, Inc. (OTC PINK:PACV) is focused on expansion within the consumer products, food, beverage and alcohol-related industries. For more information on PACV, please visit www.pacvgroup.com. (You need to be at least 21 years of age (legal age to consume alcohol) to visit the section of the website dedicated to SnöBar.)

Safe Harbor Statement

Forward-Looking Statement: This press release may contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that such forward-looking statements involve risks and uncertainties, which include but are not limited to, the inability of the company to obtain financing sufficient to maintain its operations and execute its acquisition strategy; the inherent uncertainties associated with smaller reporting companies; and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.

Investors Contact:
ir@pacvgroup.com

ClearThink
nyc@clearthink.capital

SOURCE: Pacific Ventures Group, Inc.

ReleaseID: 594712

On World Rainforest Day, Jaguar Health Reinforces Commitment to Amazon Rainforest and Sustainable Harvesting Programs for Plant-based Pharmaceuticals

Jaguar chief of sustainability and ethnobotanist Dr. Steven King speaks to Forest Trends about pharmacy of the forest, the power of Indigenous and local community knowledge, and the importance of corporate responsibility

Over the last 30 years, the Jaguar team and partner organizations have substantially invested in developing the first and only oral plant-based prescription medicine approved under FDA Botanical Guidance while setting a standard for sustainable harvesting

SAN FRANCISCO, CA / ACCESSWIRE / June 22, 2020 / Jaguar Health, Inc.'s (NASDAQ:JAGX) chief of sustainability and ethnobotanist Steven King, Ph.D. was featured on Forest Trends' Viewpoints, discussing the ancient and powerful medicinal knowledge of Indigenous peoples and local communities in the Amazon Rainforest, the importance of understanding, respecting and conserving this vast body of wisdom along with the rainforests, and the pioneering fair-trade tree-to-bottle development of Mytesi® (crofelemer) – a non-opioid oral plant-based medicine approved by the U.S. Food and Drug Administration for noninfectious diarrhea in adults patients with HIV/AIDS on antiretroviral therapy. Crofelemer, the active ingredient in Mytesi, is a plant-based drug extracted and purified from the red bark sap of the Croton lechleri tree found in the Amazon Rainforest. The article can be accessed by clicking here.

Dr. King, who also oversees ethnobotanical research and intellectual property at Jaguar, spoke with Beto Borges, director of the Communities and Territorial Governance Initiative for Forest Trends, a non-profit organization focused on driving a just and climate-secure future. Forest Trends has pioneered the idea that creating economic value in our forests and natural ecosystems is one of the most powerful incentives for sustaining them.

"It was a pleasure to join Beto to discuss the 30-year development history of Mytesi and the Croton lechleri tree's rich history of medicinal use by Indigenous peoples and local communities in South America," Dr. King said. "Our team – under the leadership of Jaguar Health's CEO Lisa Conte first at Shaman Pharmaceuticals and now at Jaguar – as well as partner organizations have invested substantial funds to bring Mytesi to market as the first and only oral plant-based prescription medicine approved under FDA Botanical Guidance while setting a standard for responsible harvesting, including planting two new trees for every tree harvested. Since 2001, approximately 800,000 trees have been planted. A close, positive relationship with Indigenous and local communities and sustainable harvesting is the right thing to do and makes good business sense." To view the investments made to support the development and commercialization of Mytesi, click here.

A non-opiate antidiarrheal indicated for the symptomatic relief of noninfectious diarrhea in adult patients with HIV/AIDS on antiretroviral therapy, Mytesi is marketed by Jaguar's wholly owned subsidiary Napo Pharmaceuticals, Inc. Napo's mission is to discover and develop novel, safe, and effective plant-based prescription medicines that relieve chronic, life-altering gastrointestinal conditions, while also ensuring that the local and Indigenous communities benefit from the harvesting and reforestation of the Croton lechleri tree. The company is also developing crofelemer as a potential treatment for cancer therapy-related diarrhea in humans and chemotherapy-induced diarrhea in dogs.

"Especially on World Rainforest Day, we need to recognize the unique and powerful knowledge traditional peoples have about plants, ecosystems, interrelationships and healing compounds. This knowledge has led to drug products that have changed the world, such as quinine did for malaria," said Dr. King. "Studies have shown that a couple of hectares of forest has more utility value for food and medicine and products than it does being harvested for timber. The forest itself can generate far more economic value over time if it is not used for short term gain. Harnessing the medicinal knowledge of traditional peoples is a vital part of the formula for preserving these important ecosystems."

During the interview with Forest Trends, Dr. King also discusses Napo's efforts to develop a second‑generation, plant-based anti‑secretory prescription medicine, lechlemer, for the symptomatic relief of diarrhea from cholera. Lechlemer, which is a drug candidate under FDA botanical guidance, is a proprietary Napo botanical extract that is distinct from Mytesi but also derived from the red bark sap of the Croton lechleri tree.

Dr. King has served as Jaguar's chief of sustainable supply, ethnobotanical research and intellectual property since 2004. Prior to that, he served as the vice president of ethnobotany and conservation at Shaman Pharmaceuticals, Inc. Dr. King has been recognized by the International Natural Products and Conservation Community for the creation and dissemination of research on the long-term sustainable harvest and management of Croton lechleri, the widespread source of crofelemer. He is currently a member of the board of directors of Healing Forest Conservatory, a California not-for-profit public benefit corporation. Dr. King holds an M.S. and Ph.D. in biology from the City University of New York (CUNY), and he received the first doctoral fellowship granted by the Institute of Economic Botany of the New York Botanical Garden.

About Forest Trends

Forest Trends works to conserve forests and other ecosystems through the creation and wide adoption of a broad range of environmental finance, markets, and other payment and incentive mechanisms. The nonprofit organization's Communities and Territorial Governance Initiative partners with Indigenous and other forest communities on innovations to secure their rights, livelihoods, and cultures through a strategy built on advocacy, economic self-determination, and cultural integrity.

About Jaguar Health, Inc.

Jaguar Health, Inc. is a commercial stage pharmaceuticals company focused on developing novel, plant-based, sustainably derived gastrointestinal products on a global basis. Our wholly owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary plant-based human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Our Mytesi® (crofelemer) product is approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy and the only oral plant-based prescription medicine approved under FDA Botanical Guidance.

For more information about Jaguar, please visit https://jaguar.health. For more information about Napo, visit napopharma.com.

About Mytesi®

Mytesi (crofelemer) is an antidiarrheal indicated for the symptomatic relief of noninfectious diarrhea in adult patients with HIV/AIDS on antiretroviral therapy (ART). Mytesi is not indicated for the treatment of infectious diarrhea. Rule out infectious etiologies of diarrhea before starting Mytesi. If infectious etiologies are not considered, there is a risk that patients with infectious etiologies will not receive the appropriate therapy and their disease may worsen. In clinical studies, the most common adverse reactions occurring at a rate greater than placebo were upper respiratory tract infection (5.7%), bronchitis (3.9%), cough (3.5%), flatulence (3.1%), and increased bilirubin (3.1%).

See full Prescribing Information at Mytesi.com. Crofelemer, the active ingredient in Mytesi, is a botanical (plant-based) drug extracted and purified from the red bark sap of the medicinal Croton lechleri tree in the Amazon Rainforest. Napo has established a sustainable harvesting program for crofelemer to ensure a high degree of quality and ecological integrity.

Forward-Looking Statements

Certain statements in this press release constitute "forward-looking statements." These include statements regarding the development of possible Mytesi (crofelemer) follow-on indications and development efforts related to lechlemer. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expect," "plan," "aim," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "estimate," "predict," "potential" or "continue" or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to a number of risks, uncertainties and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar's control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

Contact:

Peter Hodge
Jaguar Health, Inc.
phodge@jaguar.health
Jaguar-JAGX

SOURCE: Jaguar Health, Inc.

ReleaseID: 594547

American Battery Metals Corporation’s Lithium-Ion Battery Metals Recycling Plant Remains On Track to Commence Commercial Operations in the Fourth Quarter 2020

INCLINE VILLAGE, NV / ACCESSWIRE / June 22, 2020 / American Battery Metals Corporation (OTCQB:ABML) (the "Company"), an American-owned advanced extraction and battery recycling technology company with extensive mineral resources in Nevada, today announced that its Head of Business Development and Government Affairs, Doug Nickle, was recently interviewed by Proactive Investors, a UK-based online investor services company that provides analytics, market reports, and company and industry profiles. The interview focused on the global challenge of less than 5% of lithium-ion batteries being currently recycled, equating to just 90,000 metric tons and the Company's development plans for its lithium-ion battery metals recycling plant, which remains on track to commence commercial operations in the fourth quarter 2020.

To see the video interview in its entirety, please visit:

https://www.proactiveinvestors.com/companies/news/922384/american-battery-metals-gearing-up-for-clean-energy-transition-with-battery-metals-recycling-plant-922384.html

Doug Nickle tells Proactive Investors that the Nevada-based advanced technology battery recycling and resource production company is on track with its lithium-ion battery metals recycling plant to commence commercial operations in the fourth quarter 2020. The facility is designed to handle 20,000 metric tons of scrap materials and end-of-life batteries. With a global forecast of 11 million metric tons of end-of-life lithium-ion batteries expected by 2030, the Company is well-positioned to address an unmet and increasing need with its ultimate sustainable closed loop for clean energy transition and zero waste. It is becoming more and more important and could be mandated that domestic U.S. based OEMs use U.S. domestically sourced materials for manufacturing of electrical vehicle batteries. This is especially important for materials like cobalt, which is currently predominantly mined in the Congo, where ethical standards are not up to global standards and nor are they environmentally sustainable. The Company is pleased to be partnering with local, county, state and federal agencies in Nevada and the federal government, who are all enthusiastic and extremely helpful in this process. The current economic crisis has affected various global supply chains, but the Company is prepared and still on track for commercial operations to commence in the fourth quarter 2020 with its mechanical and chemical processing loops running by the second quarter of 2021.

American Battery Metals Corporation

American Battery Metals Corporation (www.batterymetals.com) (OTCQB:ABML) is an American-owned, advanced extraction and battery recycling technology company with extensive mineral resources in Nevada. The company is focused on its lithium-ion battery recycling and resource production projects in Nevada, with the goal of becoming a substantial domestic supplier of battery metals to the rapidly growing electric vehicle and battery storage markets.

For more information, please visit:www.batterymetals.com

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including those with respect to the expected project economics for Western Nevada Basin (Railroad Valley), including estimates of life of mine, average production, cash costs, AISC, initial CAPEX, sustaining CAPEX, pre-tax IRR, pre-tax NPV, net cash flows and recovery rates, the impact of self-mining versus contract mining, the timing to obtain necessary permits, the submission of the project for final investment approval and the timing of initial gold production after investment approval and full financing, metallurgy and processing expectations, the mineral resource estimate, expectations regarding the ability to expand the mineral resource through future drilling, ongoing work to be conducted at the Western Nevada Basin (Railroad Valley), and the potential results of such efforts, the potential commissioning of a Pre-Feasibility study and the effects on timing of the project, are "forward-looking statements." Although the Company's management believes that such forward-looking statements are reasonable, it cannot guarantee that such expectations are, or will be, correct. These forward-looking statements involve a number of risks and uncertainties, which could cause the Company's future results to differ materially from those anticipated. Potential risks and uncertainties include, among others, interpretations or reinterpretations of geologic information, unfavorable exploration results, inability to obtain permits required for future exploration, development or production, general economic conditions and conditions affecting the industries in which the Company operates; the uncertainty of regulatory requirements and approvals; fluctuating mineral and commodity prices, final investment approval and the ability to obtain necessary financing on acceptable terms or at all. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company's filings with the Securities and Exchange Commission, including the Annual Report on Form 10-K for the year ended September 30, 2019. The Company assumes no obligation to update any of the information contained or referenced in this press release.

Contact Information
p775-473-4744
info@batterymetals.com

ClearThink
nyc@clearthink.capital

SOURCE: American Battery Metals Corporation

ReleaseID: 594711